Even more discussions from the content while in the pharmaceutical Group of every submodel are necessary to achieve a common template, comparable to the initiatives in I4.0 from the IDTA 21 Figure two.1 shows how an AAS is used and transferred among a provider and an integrator. The supplier generates the AAS for their assets (product or servic